603 related articles for article (PubMed ID: 35643209)
1. Bioactive compounds with antifungal activity against pathogens isolated from pregnant woman: Gallesia integrifolia (garlic wood) is a promising treatment for vulvovaginal candidiasis.
de Souza ANV; Faria MGI; da Rocha CE; Philippsen GS; Silva GCC; da Silva GR; Inumaro RS; Gonçalves JE; Gazim ZC; Wietzikoski S; Lívero FADR; Seixas FAV; Wietzikoski Lovato EC
J Ethnopharmacol; 2022 Sep; 295():115403. PubMed ID: 35643209
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
3. Antifungal effects of Lavandula binaludensis and Cuminum cyminum essential oils against Candida albicans strains isolated from patients with recurrent vulvovaginal candidiasis.
Minooeianhaghighi MH; Sepehrian L; Shokri H
J Mycol Med; 2017 Mar; 27(1):65-71. PubMed ID: 27751723
[TBL] [Abstract][Full Text] [Related]
4. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
[TBL] [Abstract][Full Text] [Related]
5. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
[TBL] [Abstract][Full Text] [Related]
8. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
[TBL] [Abstract][Full Text] [Related]
9. Novel Preclinical Study of Galloylquinic Acid Compounds from
Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
11. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
Hacioglu M; Guzel CB; Savage PB; Tan ASB
Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp.
Hammer KA; Carson CF; Riley TV
J Antimicrob Chemother; 1998 Nov; 42(5):591-5. PubMed ID: 9848442
[TBL] [Abstract][Full Text] [Related]
14. Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida.
Mandras N; Nostro A; Roana J; Scalas D; Banche G; Ghisetti V; Del Re S; Fucale G; Cuffini AM; Tullio V
BMC Complement Altern Med; 2016 Aug; 16(1):330. PubMed ID: 27576581
[TBL] [Abstract][Full Text] [Related]
15. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
16. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period.
Intra J; Sala MR; Brambilla P; Carcione D; Leoni V
J Mycol Med; 2022 Aug; 32(3):101278. PubMed ID: 35523109
[TBL] [Abstract][Full Text] [Related]
18. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Bitew A; Abebaw Y
BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
[TBL] [Abstract][Full Text] [Related]
19. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
[TBL] [Abstract][Full Text] [Related]
20. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
